Skip to main content
. 2022 Mar 11;7(2):100458. doi: 10.1016/j.esmoop.2022.100458

Figure 1.

Figure 1

SARS-CoV-2 IgG levels and NT Abs titre.

Total immunoglobulin G (IgG) (A) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibodies (NT Abs) (B) were measured at the time of the booster dose administration (T0) and after 3 weeks (T1) in SARS-CoV-2-naïve solid organ cancer patients and SARS-CoV-2-experienced solid organ cancer patients.

Median levels of response are shown in the graph. P values are given for each comparison.